Journal
NATURE NANOTECHNOLOGY
Volume 10, Issue 1, Pages 65-69Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/NNANO.2014.285
Keywords
-
Funding
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077173] Funding Source: NIH RePORTER
- NIGMS NIH HHS [R01 GM077173, GM077173] Funding Source: Medline
Ask authors/readers for more resources
Screening methods that use traditional genomic(1-3), transcriptional(4), proteomic(5,6) and metabonomic(7) signatures to characterize drug mechanisms are known. However, they are time consuming and require specialized equipment. Here, we present a high-throughput multichannel sensor platform that can profile the mechanisms of various chemotherapeutic drugs in minutes. The sensor consists of a gold nanoparticle complexed with three different fluorescent proteins that can sense drug-induced physicochemical changes on cell surfaces(8-10). In the presence of cells, fluorescent proteins are rapidly displaced from the gold nanoparticle surface and fluorescence is restored. Fluorescence 'turn on' of the fluorescent proteins depends on the drug-induced cell surface changes, generating patterns that identify specific mechanisms of cell death induced by drugs. The nanosensor is generalizable to different cell types and does not require processing steps before analysis, offering an effective way to expedite research in drug discovery, toxicology and cell-based sensing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available